Fig. 2From: Interstitial lung disease is a dominant feature in patients with circulating myositis-specific antibodiesFrequency of lung, muscle, and skin involvement among the study population (n = 36) of individuals with positive circulating myositis-specific antibodies (MSAs). p < 0.0001 by Chi-squared testBack to article page